Barclay luke & Pillai Specialty Pharmacy PLLC

Form 483 issued December 9, 2022 · Las Vegas, Nevada

Inspection
Nov 28 – Dec 9, 2022
Observations
7
Pages
8
FEI number
3011888866

In short: On December 9, 2022, FDA issued a Form 483 with 7 observations to Barclay luke & Pillai Specialty Pharmacy PLLC in Las Vegas, Nevada (FEI 3011888866) after an inspection that ran Nov 28 – Dec 9, 2022. The investigator was Christopher R. Czajka. Most observations concern facilities & equipment and laboratory controls.

At a glance

Observations span 4 systems, led by facilities & equipment.

Facilities & equipment1
Laboratory controls1
Materials1
Production1
Other3

Most cited: FDCA 501(a)(2)(A) (3×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01
    FDCA 501(a)(2)(A)

    The ISO 5 classified aseptic processing areas had difficult to clean and visibly…

  2. 02
    FDCA 501(a)(2)(A)

    Non-microbial contamination was observed…

  3. 03

    You produced hazardous diugs without providing adequate…

  4. 04
    FDCA 501(a)(2)(A)

    Unsealed, loose ceiling tiles were…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Barclay luke & Pillai Specialty Pharmacy PLLC?

FDA listed 7 observations on this Form 483, mostly about facilities & equipment, laboratory controls and materials. The opening words of each observation are shown on this page.

Who inspected Barclay luke & Pillai Specialty Pharmacy PLLC?

Christopher R. Czajka is named on this Form 483, for the inspection of Nov 28 – Dec 9, 2022. Each investigator has a profile showing what they cite most.

When was Barclay luke & Pillai Specialty Pharmacy PLLC inspected by FDA?

The inspection ran Nov 28 – Dec 9, 2022, and the Form 483 is dated December 9, 2022.

How do I get the full Form 483 for Barclay luke & Pillai Specialty Pharmacy PLLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free